secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vera Therapeutics, Inc. (VERA)
CIK:        0001831828
Form:       8-K
Filed at:   2022-04-12T23:59:59+00:00
Accession:  0001193125-22-102911
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Vera Therapeutics names Michael Morrissey Ph.D. as Board Chair; von Emster resigns
--------------------------------------------------------------------------------

- Kurt von Emster resigns as director and Chair effective at 2022 annual meeting; no dispute.
- Michael Morrissey appointed to Board, becomes Chair, Class II director, term through 2023 annual meeting.
- Morrissey receives option grant of 40,000 shares (vs. standard 19,850) vesting over 3 years.
- Cash retainers: $65k as Chair, $7.5k on Audit Committee, $4k on Nominating Committee, pro-rated for 2022.
- Morrissey also appointed to Audit and Nominating Committees, effective annual meeting date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831828/000119312522102911/0001193125-22-102911-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831828/000119312522102911/d323101d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-102911

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer